Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | PTCT | PTC THERAPEUTICS INC | Healthcare | 6,000.0 | $409K | 0.29% | -1K | -14.8% | $68.13 | +2.9% |
| 22 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 11,000.0 | $400K | 0.28% | -316.0 | -2.8% | $36.32 | +133.6% |
| 23 | STOK | STOKE THERAPEUTICS INC | Healthcare | 12,000.0 | $391K | 0.28% | -5K | -27.8% | $32.56 | -2.9% |
| 24 | KOD | KODIAK SCIENCES INC | Healthcare | 10,000.0 | $381K | 0.27% | -9K | -48.5% | $38.12 | -1.0% |
| 25 | DYN | DYNE THERAPEUTICS INC | Healthcare | 20,000.0 | $363K | 0.26% | -2K | -7.1% | $18.13 | +38.3% |
| 26 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,000.0 | $316K | 0.22% | -3K | -51.0% | $105.40 | +36.9% |
| 27 | MDGL | MADRIGAL PHARMACEUTICALS INC | Healthcare | 600.0 | $314K | 0.22% | -292.0 | -32.7% | $523.47 | +2.0% |
| 28 | SUPN | SUPERNUS PHARMACEUTICALS | Healthcare | 6,000.0 | $310K | 0.22% | -5K | -44.2% | $51.69 | -15.4% |
| 29 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 5,159.0 | $260K | 0.18% | -11K | -67.4% | $50.44 | +79.1% |
| 30 | — | ZYMEWORKS INC | — | 10,000.0 | $250K | 0.18% | -10K | -50.8% | $25.04 | — |
| 31 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 4,200.0 | $244K | 0.17% | -7K | -64.0% | $58.15 | +3.2% |
| 32 | CELC | CELCUITY INC | Healthcare | 2,000.0 | $228K | 0.16% | -3K | -61.9% | $114.14 | -22.5% |
| 33 | LEGN | LEGEND BIOTECH CORP | Healthcare | 12,000.0 | $217K | 0.15% | -12K | -50.8% | $18.09 | +9.9% |
| 34 | ALKS | ALKERMES PLC | Healthcare | 6,000.0 | $212K | 0.15% | -13K | -68.9% | $35.36 | +34.1% |
| 35 | — | APOGEE THERAPEUTICS INC | — | 2,500.0 | $210K | 0.15% | -4K | -64.2% | $84.17 | — |
| 36 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 350.0 | $208K | 0.15% | -730.0 | -67.6% | $592.98 | -13.1% |
| 37 | AMLX | AMYLYX PHARMACEUTICALS INC | Healthcare | 10,838.0 | $151K | 0.11% | -33K | -75.5% | $13.90 | +149.9% |
| 38 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 10,000.0 | $149K | 0.10% | -9K | -47.5% | $14.91 | -31.1% |
| 39 | EYPT | EYEPOINT INC | Healthcare | 10,000.0 | $129K | 0.09% | -20K | -66.1% | $12.89 | -65.2% |
| 40 | OCUL | OCULAR THERAPEUTIX INC | Healthcare | 15,000.0 | $127K | 0.09% | -28K | -65.0% | $8.47 | +22.3% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%